Hyperlipidemia News and Research

RSS

Hyperlipidemia, hyperlipoproteinemia or dyslipidemia is the presence of raised or abnormal levels of lipids and/or lipoproteins in the blood. Lipids (fatty molecules) are transported in a protein capsule, and the density of the lipids and type of protein determines the fate of the particle and its influence on metabolism.

Study suggests limiting oral corticosteroid use to 90 days reduces adverse effects in atopic dermatitis patients

Researchers evaluated the association between long-term oral corticosteroid use and adverse events in adult patients with atopic dermatitis.

24 Jul 2024

New study sheds light on irregular heartbeat risk

Two new, basic animal research studies shed light on alcohol consumption and the heart. The first study may help explain why binge drinking sometimes causes an irregular heartbeat and a possible way to prevent it. The second study investigated why alcohol may have a negative impact on heart function in women taking estrogen replacement therapy.

23 Jul 2024

Irregular sleep and poor REM sleep linked to higher risk of chronic diseases

Longitudinal data from wearable devices linked to health records show that irregular sleep patterns and inadequate REM sleep increase the risk of chronic diseases like hypertension and depression. This emphasizes the importance of consistent and high-quality sleep for overall health.

22 Jul 2024

Study suggests shift work increases risk of premature ejaculation in men

A recent study links shift work and shift work sleep disorder (SWSD) to an increased risk of premature ejaculation (PE) in male workers. The findings highlight how sleep disruptions and prolonged shift work impact reproductive health.

7 Jul 2024

Fibrinogen-like protein 1 plays dual role in liver regeneration and hepatocellular carcinoma recurrence

Hepatocellular carcinoma (HCC), a leading cause of cancer-related mortality globally, exhibits a dismal five-year survival rate of only 18%.

2 Jul 2024

Global burden of heart failure: prevalence, incidence, and risk factors unveiled

Review provides a comprehensive overview of the global burden of heart failure, highlighting variations in prevalence, incidence, risk factors, and outcomes across different geographical regions and populations.

30 Jun 2024

Study reveals metabolic syndrome's impact on brain volume and cognitive function

Associations between metabolic syndrome (MetS) and cognitive and neuroimaging outcomes in dementia-free adults.

24 Jun 2024

Perinatal depression may increase cardiovascular disease risk

Women with perinatal depression have a 36% higher risk of developing cardiovascular disease, particularly hypertensive disease, ischemic heart disease, and heart failure, as shown in a Swedish nationwide study.

23 Jun 2024

Facial temperature can predict heart disease with higher accuracy than current methods

Researchers found that facial infrared thermography can predict coronary artery disease more accurately than traditional pretest probability tools, using deep-learning algorithms to analyze temperature patterns.

6 Jun 2024

Garlic proves potent in reducing blood sugar and cholesterol, study reveals

Study confirms garlic's significant benefits in lowering blood glucose and lipid levels, offering a natural remedy for metabolic disorders.

2 Jun 2024

Type 2 diabetes linked to higher cancer risk, especially with diabetic retinopathy, study finds

A recent study in BMC Medicine found that type 2 diabetes significantly increases the risk of various cancers, with the risk being even higher in patients with diabetic retinopathy (DR).

2 Jun 2024

COVID-19 associated with higher risk of erectile dysfunction

Men previously diagnosed with COVID-19 are at a greater risk of developing new-onset erectile dysfunction.

31 May 2024

RNA interference agent plozasiran targets APOC3 for effective mixed hyperlipidemia treatment

Researchers evaluate the efficacy of plazosiran treatment on fasting triglyceride levels in adult patients with mixed hyperlipidemia.

31 May 2024

RNA-based therapy shows promise in reducing cholesterol and triglycerides

A small interfering RNA (siRNA) investigational therapy that inhibits a gene involved in lipoprotein metabolism has been shown in a clinical trial led by Mount Sinai researchers to significantly reduce levels of different types of cholesterol and triglycerides in individuals with mixed hyperlipidemia, a condition in which fats build up in the blood.

29 May 2024

Increased risk of erectile dysfunction with semaglutide in non-diabetic obese patients

Researchers found that semaglutide treatment for weight loss in non-diabetic, obese men is associated with an increased risk of erectile dysfunction and testosterone deficiency.

26 May 2024

Anti-obesity medications slash heart disease risk in obese patients, study finds

A study in the journal Obesity evaluated the impact of new anti-obesity medications (AOMs) on cardiovascular disease (CVD) among obese individuals, finding that these medications reduce the risk of CVD complications, particularly heart failure and atrial fibrillation.

15 May 2024

Metabolomic analysis sheds light on gut microbes' role in cardiovascular disease risk

The effect of gut bacteria on non-high-density lipoprotein cholesterol (non-HDL-c) variations.

14 May 2024

New study shows age, sex, race crucial for predicting mortality risks in older adults

Study finds that the LS7 and LE8 scores predict all-cause and cardiovascular mortality with similar efficacy in the overall U.S. population. However, the PCE score is better at predicting mortality in individuals aged 40 to 79.

5 May 2024

Cinnamon, curcumin, and resveratrol show promise in diabetes inflammation fight

Researchers reviewed the impact of cinnamon, curcumin, and resveratrol on oxidative stress and inflammation in type 2 diabetes patients, highlighting their potential to improve metabolic regulation and reduce complications.

26 Apr 2024

Linking lifestyle to longevity: How diet and hypertension sway risks for heart disease and cancer

Study reviews epidemiological evidence linking modifiable risk factors like diet and hypertension to both cardiovascular disease (CVD) and cancer, suggesting a shared pathophysiology and potential strategies for simultaneous prevention and management.

11 Apr 2024